cas 1686150-29-7|| where to buy Trifluoro(pyrrolidin-1-ium-1-ylmethyl)boranuide

Product Name:Trifluoro(pyrrolidin-1-ium-1-ylmethyl)boranuide

IUPAC Name:trifluoro[(pyrrolidin-1-ium-1-yl)methyl]boranuide

Packing Unit	Available Stock	Price($)
CM250194-5g	in stock	ƙț
CM250194-25g	in stock	ƀɅȬ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1686150-29-7 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:1686150-29-7; Molecular Formula:C5H11BF3N; Melting Point:-; Smiles Code:F[B-](F)(F)C[NH+]1CCCC1; Density:

: Catalog Number:CM250194; Molecular Weight:152.96; Boiling Point:; MDL No:; Storage:Store at 2-8°C.

: Borates; Borates are classified as critical materials, they are the main source of boron and have a variety of industrial applications. Organic trifluoroborate is stable to heat, air and humidity, and is a very convenient crystalline boric acid compound. Since it has a tetra-coordinated boronic acid structure after the substitution of fluorine, it does not exhibit Lewis acidity and is stable to oxidation conditions. In addition, it can be regarded as the protector of boronic acid and boronic acid ester, which can be converted into each other. The compound can generally exist stably in organic solvents, but will decompose in protic solvents to liberate trivalent boron, so it can be directly used as a substrate for Suzuki coupling. The difference between trifluoroborate and boric acid is that it must exist in a monomeric form, so the equivalent weight can be closely controlled.

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.